SBC Medical Group Holdings (SBC) closed at $5.17 on November 20, 2026, down 7.7% from the previous close, on volume of 364,238 shares (30-day average 295,299).
Data as of November 20, 2026.
20-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 19, 2026. See the largest for 5, 30, 60 and 90 days
Globe Newswire (Fri, 20-Nov 4:00 PM ET)
TipRanks (Fri, 20-Nov 5:31 AM ET)
SBC Medical Group Reports Major Data Security Breach
TipRanks (Thu, 19-Nov 10:22 AM ET)
Market Chameleon (Thu, 19-Nov 4:52 AM ET)
Maxim Group Remains a Buy on SBC Medical Group Holdings (SBC)
TipRanks (Thu, 19-Nov 8:26 AM ET)
SBC Medical Group Reports Cybersecurity Incidents in Japan
Business Wire (Wed, 18-Nov 11:39 PM ET)
Market Chameleon (Fri, 13-Nov 2:57 AM ET)
SBC Medical Group Holdings Reports Third Quarter 2026 Financial Results
Business Wire (Fri, 13-Nov 6:30 AM ET)
Business Wire (Fri, 13-Nov 6:30 AM ET)
Shonan Beauty Clinic Named to Newsweek's 'World's Best Hospitals & Clinics for Medical Tourism 2027'
Business Wire (Thu, 5-Nov 9:00 AM ET)
SBC Medical Group Holdings Inc is a management company that provides management services to cosmetic treatment centers mainly in Japan. It is focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale). The firm generates revenue mostly from these management services.
SBC Medical Group Holdings trades on the NASDAQ stock market under the symbol SBC.
As of November 20, 2026, SBC stock price declined to $5.17 with 364,238 million shares trading.
SBC has a beta of 1.90, meaning it tends to be more sensitive to market movements. SBC has a correlation of 0.16 to the broad based SPY ETF.
SBC has a market cap of $530.32 million. This is considered a Small Cap stock.
Last quarter SBC Medical Group Holdings reported $59 million in Revenue and $.15 earnings per share. This beat revenue expectation by $10 million and exceeded earnings estimates by $.03.
The top ETF exchange traded funds that SBC belongs to (by Net Assets): IWM, AVUV, VXF, IWN, VTWO.
SBC has outperformed the market in the last year with a price return of +66.5% while the SPY ETF gained +6.9%. SBC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +40.5% and +2.6%, respectively, while the SPY returned -9.3% and -6.2%, respectively.
SBC support price is $5.32 and resistance is $5.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SBC shares will trade within this expected range on the day.